Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 852Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

MONITORING

Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verification

De Sourabh

Year : 2011| Volume: 2| Issue : 3 | Page no: 100-104

   This article has been cited by
 
1 Self-audits as alternatives to travel-audits for improving data quality in the Caribbean, Central and South America network for HIV epidemiology
Sarah C. Lotspeich,Mark J. Giganti,Marcelle Maia,Renalice Vieira,Daisy Maria Machado,Regina Célia Succi,Sayonara Ribeiro,Mario Sergio Pereira,Maria Fernanda Rodriguez,Gaetane Julmiste,Marco Tulio Luque,Yanink Caro-Vega,Fernando Mejia,Bryan E. Shepherd,Catherine C. McGowan,Stephany N. Duda
Journal of Clinical and Translational Science. 2020; 4(2): 125
[Pubmed]  [Google Scholar] [DOI]
2 Heterogeneity in clinical research data quality monitoring: a national survey
Lauren Houston,Ping Yu,Allison Martin,Yasmine Probst
Journal of Biomedical Informatics. 2020; : 103491
[Pubmed]  [Google Scholar] [DOI]
3 Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan
Tomohisa Sudo,Akihiro Sato
Therapeutic Innovation & Regulatory Science. 2017; 51(5): 589
[Pubmed]  [Google Scholar] [DOI]
4 The impact of clinical trial monitoring approaches on data integrity and cost—a review of current literature
Rasmus Olsen,Asger Reinstrup Bihlet,Faidra Kalakou,Jeppe Ragnar Andersen
European Journal of Clinical Pharmacology. 2016;
[Pubmed]  [Google Scholar] [DOI]
5 Data-driven risk identification in phase III clinical trials using central statistical monitoring
Catherine Timmermans,David Venet,Tomasz Burzykowski
International Journal of Clinical Oncology. 2016; 21(1): 38
[Pubmed]  [Google Scholar] [DOI]
6 Efficient Source Data Verification Using Statistical Acceptance Sampling
Rutger M. van den Bor,Bas J. Oosterman,Martinus B. Oostendorp,Diederick E. Grobbee,Kit C. B. Roes
Therapeutic Innovation & Regulatory Science. 2016; 50(1): 82
[Pubmed]  [Google Scholar] [DOI]
7 Evolving quality standards for large-scale registries: the GARFIELD-AF experience
Keith A.A. Fox,Bernard J. Gersh,Sory Traore,A. John Camm,Gloria Kayani,Anders Krogh,Shweta Shweta,Ajay K. Kakkar
European Heart Journal - Quality of Care and Clinical Outcomes. 2016; : qcw058
[Pubmed]  [Google Scholar] [DOI]
8 A Data-Driven Approach to Risk-Based Source Data Verification
Elizabeth Nielsen,DeAnn Hyder,Chao Deng
Therapeutic Innovation & Regulatory Science. 2014; 48(2): 173
[Pubmed]  [Google Scholar] [DOI]
9 Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials
Nicole Sheetz,Brett Wilson,Joanne Benedict,Esther Huffman,Andy Lawton,Mark Travers,Patrick Nadolny,Stephen Young,Kyle Given,Lawrence Florin
Therapeutic Innovation & Regulatory Science. 2014; 48(6): 671
[Pubmed]  [Google Scholar] [DOI]
10 Key Considerations in the Transition to Risk-Based Monitoring
Michael J. Rosenberg
Therapeutic Innovation & Regulatory Science. 2014; 48(4): 428
[Pubmed]  [Google Scholar] [DOI]
11 Taking the 'Risk' out of risk-based monitoring
Ashwaria Gupta
Perspectives in Clinical Research. 2013; 4(4): 193
[Pubmed]  [Google Scholar] [DOI]

 

Read this article